| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
4.03 0 (0%) |
04-18 12:18 |
|
Open: |
4.05 |
Pre close: |
4.03 |
Target:
|
5.19
|
|
High: |
4.05 |
Low: |
3.9201 |
Resistance:
|
4.44
5.19
|
|
Volume: |
13,600 |
Market Cap: |
70M |
Support:
|
3.67
 3.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.05
 |
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
3.80 |
Signal(12,26,9): |
0.20 |
|
MA(100): |
3.53 |
Stochastic Oscillator |
%K(14,3):
|
58.82 |
|
MA(250): |
4.81 |
%D(3): |
64.41 |
|
Average Volume(K) |
3-Month: |
7400
|
52-Week |
High:
|
8.59 |
|
10-Days: |
12734 |
Low: |
2.78 |
|
RSI |
RSI(14):
|
59.00 |
Change(%): |
-46.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.860 |
Return on Equity (ttm) |
-56.2 |
Shares Out. (M) |
17.38 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-34.1 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.90 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.510 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.58 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
405874112.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
